Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Simultaneous Activation of p53 and Inhibition of XIAP Enhance the Activation of Apoptosis Signaling Pathways in AML.

Bing Z. Carter, PhD, Duncan H. Mak, Wendy D. Schober, Erich Koller, PhD, Clemencia Pinilla, PhD, Lyubomir T. Vassilev, PhD, John C. Reed, MD, PhD, Michael Andreeff, MD, PhD

Blood (2008) 112 (11): 1941.

https://doi.org/10.1182/blood.V112.11.1941.1941

Published: 2008

Journal Articles

Small-Molecule XIAP Antagonist Restores Caspase-9-Mediated Apoptosis in XIAP-Positive Diffuse Large B-Cell Lymphoma Cells.

Saskia A.G.M. Cillessen, MSc, John C. Reed, PhD MD, Clemencia Pinilla, PhD, Chris J.L.M. Meijer, PhD MD, Erik Hooijberg, PhD, Corine J. Hess, MD, Kitty C.M. Castricum, Pim Kortman, Gert J. Ossenkoppele, PhD MD, Joost J. Oudejans, PhD MD

Blood (2007) 110 (11): 803.

https://doi.org/10.1182/blood.V110.11.803.803

Published: 2007

Journal Articles

Inhibition of XIAP Renders Newly CD40-Activated Chronic Lymphocytic Leukemia Cells Sensitive to Fas (CD95) Mediated Apoptosis.

Arnon P. Kater, MD, Frank Dicker, PhD, Massimo Mangiola, PhD, Kate Welsh, John Ostresh, PhD, Richard Houghten, PhD, John C. Reed, MD, PhD, Thomas J. Kipps, MD, PhD, Clemencia Pinilla, PhD

Blood (2004) 104 (11): 3474.

https://doi.org/10.1182/blood.V104.11.3474.3474

Published: 2004

Journal Articles

Inhibition of XIAP Enhances Specific Cytotoxic T Lymphocyte (CTL) Killing and CD20-Directed Antibody-Dependent Cellular Cytotoxicity of Chronic Lymphocytic Leukemia B Cells.

Arnon P. Kater, MD, Roman Rieger, PhD, Kate Welsh, PhD, Adel Nefzi, PhD, Richard Houghten, PhD, John C. Reed, MD. PhD, Clemencia Pinilla, PhD, Thomas J. Kipps, MD, PhD

Blood (2004) 104 (11): 3475.

https://doi.org/10.1182/blood.V104.11.3475.3475

Published: 2004

Journal Articles

Small-Molecule XIAP Inhibitors Derepress Downstream Effector Caspases and Induce Apoptosis of Leukemia Cell Lines and Patient Samples.

Aaron D. Schimmer, MD, PhD, Marcela Gronda, MSc, Zhiliang Wang, PhD, Kate Welsh, PhD, Clemencia Pinilla, PhD, Michael Andreeff, MD, PhD, Wendy D. Schober, Adel Nefzi, PhD, Richard Houghten, PhD, Joseph Brandwein, MD, Mark D. Minden, MD, PhD, Andre Schuh, MD, PhD, Richard A. Wells, MD, PhD, Hans Messner, MD, PhD, John C. Reed, MD, PhD, Bing Z. Carter, PhD

Blood (2004) 104 (11): 759.

https://doi.org/10.1182/blood.V104.11.759.759

Published: 2004

NARROW

Simultaneous Activation of p53 and Inhibition of XIAP Enhance the Activation of Apoptosis Signaling Pathways in AML.

Small-Molecule XIAP Antagonist Restores Caspase-9-Mediated Apoptosis in XIAP-Positive Diffuse Large B-Cell Lymphoma Cells.

Inhibition of XIAP Renders Newly CD40-Activated Chronic Lymphocytic Leukemia Cells Sensitive to Fas (CD95) Mediated Apoptosis.

Inhibition of XIAP Enhances Specific Cytotoxic T Lymphocyte (CTL) Killing and CD20-Directed Antibody-Dependent Cellular Cytotoxicity of Chronic Lymphocytic Leukemia B Cells.

Small-Molecule XIAP Inhibitors Derepress Downstream Effector Caspases and Induce Apoptosis of Leukemia Cell Lines and Patient Samples.

Email alerts

ASH Publications

American Society of Hematology

Simultaneous Activation of p53 and Inhibition of XIAP Enhance the Activation of Apoptosis Signaling Pathways in AML.

Small-Molecule XIAP Antagonist Restores Caspase-9-Mediated Apoptosis in XIAP-Positive Diffuse Large B-Cell Lymphoma Cells.

Inhibition of XIAP Renders Newly CD40-Activated Chronic Lymphocytic Leukemia Cells Sensitive to Fas (CD95) Mediated Apoptosis.

Inhibition of XIAP Enhances Specific Cytotoxic T Lymphocyte (CTL) Killing and CD20-Directed Antibody-Dependent Cellular Cytotoxicity of Chronic Lymphocytic Leukemia B Cells.

Small-Molecule XIAP Inhibitors Derepress Downstream Effector Caspases and Induce Apoptosis of Leukemia Cell Lines and Patient Samples.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only